Spirulina (Arthrospira platensis, Arthrospira maxima)
Spirulina is the dried biomass of a blue-green photosynthetic bacterium (Arthrospira platensis and A. maxima), sold in the UK as a food supplement, principally for plant-based protein contribution and as a "green superfood". Despite the popular name, spirulina is NOT a true algae — it's a cyanobacterium. There are NO UK-authorised health claims for spirulina — EFSA's evaluation of spirulina-related claims is on hold. Two consumer-education points genuinely matter: 1. <strong>Do NOT rely on spirulina as your vitamin B12 source if you're vegan.</strong> The B12-like molecules in spirulina are pseudo-B12 analogues your body cannot use, and there is published concern (Watanabe 2002, 2014) that they may compete with active B12 at the absorption-receptor and worsen functional B12 status. UK BDA and Vegan Society guidance is unambiguous on this: vegans need methylcobalamin or cyanocobalamin supplements (or B12-fortified foods). 2. <strong>Spirulina cultivation is open-pond and vulnerable to contamination by toxin-producing Microcystis bacteria (microcystin).</strong> Documented clinical episodes have occurred from contaminated commercial product. Reputable suppliers screen each batch for microcystin (LC-MS or ELISA) and BMAA (β-methylamino-L-alanine, a neurotoxic concern associated with some cyanobacteria). Look for the batch- testing disclosure on the spec sheet. The cardiovascular evidence base is modest. Hoang 2021 Phytotherapy Research umbrella review (PMID 33724587) listed spirulina alongside Aloe vera and Nigella sativa as phytonutrients with beneficial effects on lipid profiles and glycemic control. Machowiec 2021 Nutrients (PMID 34578932, 5 RCTs n=230) reported SBP -4.6 mmHg + DBP -7.0 mmHg particularly in hypertensive patients. UK NICE NG238 + NG136 do NOT include spirulina in any pathway.
Camden Medicals editorial · Last reviewed 12 May 2026 · Next review May 2027
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Other
- Typical daily dose
- Trial-evidenced doses span 1-8 g/day of dried biomass (commonly delivered as 6-12 tablets/day). UK supplement labels typically recommend 3-6 g/day. Higher doses are not proportionally better-evidenced.
- Top use evidence
- Strong
On this page
What it is
Spirulina is a blue-green microscopic bacterium that grows in warm, alkaline lakes — the kind of conditions you'd find in volcanic crater lakes or salt flats. It was eaten by the Aztecs (under the name teōtīcūitl, harvested from Lake Texcoco in central Mexico) and is still gathered for food by the Kanembu people around Lake Chad. Today nearly all commercial spirulina is grown in artificial open ponds in Hawaii, southern California, Spain, Israel, India, and China, then dried and milled into the dark green-blue powder you see on UK supplement shelves.
Spirulina is the common (commercial) name for two cyanobacterium species in the genus Arthrospira: Arthrospira platensis and Arthrospira maxima. (The genus was historically called Spirulina, hence the persistent common name; modern taxonomy reserves Spirulina for a distinct genus, but the supplement industry has retained the older name.) These are filamentous, helical-coiled, photosynthetic cyanobacteria — single-celled prokaryotes that generate energy through oxygenic photosynthesis like plants and true algae but are taxonomically distinct from both.
Wild populations of Arthrospira occur in alkaline lakes (high-pH, high-carbonate water) in tropical and subtropical regions — Lake Texcoco in central Mexico, Lake Chad in west-central Africa, lakes of the East African Rift, and in commercial open-pond cultivation in Hawaii, southern California, Spain, Israel, India, and China. Commercial spirulina is harvested from cultivation ponds, dried (typically by spray-drying or sun-drying), and milled into powder for supplement and food-ingredient use.
Compositional profile per 100 g dry biomass:
- Protein ~60-70% by dry weight, with a complete amino-acid profile.
- Lipids ~5-7%, with a meaningful gamma-linolenic acid (GLA, n-6) content.
- Carbohydrates ~15-25%, including the phycocyanin pigment-protein complex.
- Phycocyanin (the standardisation marker for trial-grade material) — typically 6-20% by dry weight.
- Chlorophyll a — gives spirulina its dark green undertone alongside the blue phycocyanin.
- β-carotene — modest content.
- Iron — typically 28-40 mg / 100 g dry weight, but bioavailability is moderate.
- B vitamins — including thiamine, riboflavin, niacin, and a corrinoid B12-analogue that is NOT bioavailable as active vitamin B12 (see mechanism section).
UK supplement preparations are sold as:
- Whole-biomass dried powder (typical loose powder or capsule).
- Tablets (compressed dried biomass, often without binders).
- Phycocyanin-standardised extracts (more concentrated colour / pigment content; less protein per gram).
- Combination products with chlorella, wheatgrass, barley grass, or other green-superfood ingredients.
UK food-supplement-tier spirulina has NO authorised UK health claim. EFSA Article 13 evaluations for spirulina-related claims (general protein supplementation, antioxidant, immune support, lipid maintenance) are on hold and have not been approved.
At a glance
- Cyanobacterium (NOT a true alga). UK food supplement with NO UK-authorised health claims; EFSA Article 13 claims for spirulina on hold.
- AVOID as a vegan B12 source. The B12-like corrinoids in spirulina are pseudo-B12 — non-bioavailable and may interfere with active B12 absorption. Use methylcobalamin or cyanocobalamin instead.
- Microcystin contamination risk in open-pond cultivation — reputable suppliers screen each batch for microcystin (LC-MS or ELISA) and BMAA. Look for the spec-sheet disclosure.
- AVOID in phenylketonuria (PKU) — spirulina is ~3-5% phenylalanine by dry weight; CONTRAINDICATED for people with PKU on phenylalanine-restricted diets.
- Cardiovascular signal: Machowiec 2021 PMID 34578932 (5 RCTs n=230) — SBP -4.6 mmHg + DBP -7.0 mmHg particularly in hypertensive patients. Hoang 2021 PMID 33724587 umbrella review — spirulina among phytonutrients with beneficial lipid + glycemic effects. UK NICE NG238 + NG136 do NOT include spirulina in any pathway.
- Active constituents: phycocyanin (the blue pigment standardisation marker), gamma-linolenic acid (GLA), modest β-carotene, modest iron, ~60-70% protein dry weight.
- Pregnancy and breastfeeding: limited data. Avoid concentrated supplement extracts. Theoretical immunomodulation makes spirulina worth disclosing to clinicians managing autoimmune disease or immunosuppressant therapy.
What people use it for
Plant-based eaters using spirulina for protein contribution
Spirulina contributes 4-5 g of plant-protein per 6-7 g serving (typical 6-tablet daily dose) — a meaningful but modest contribution to daily protein intake. UK NHS Eatwell Guide protein-source recommendations include legumes, tofu, nuts, seeds, and whole grains as the primary plant-protein sources; spirulina is an adjunct. Cost-per-gram-protein is much higher than other plant-protein sources. [2]
Some evidenceLimitedVegans using spirulina as a vitamin B12 source
DO NOT rely on spirulina for vitamin B12. The B12 detected on spirulina labels is principally a corrinoid analogue (pseudovitamin B12) that is NOT human-bioavailable as active vitamin B12 and may interfere with active-B12 utilisation in heavy users. Vegans need active vitamin B12 — methylcobalamin or cyanocobalamin supplements (typically 25-1000 µg/day depending on regimen) or B12-fortified foods (UK plant drinks, nutritional yeast, breakfast cereals). The UK BDA and Vegan Society both flag spirulina as NOT a reliable B12 source. UK NHS pathway for suspected B12 deficiency is GP review and serum B12 / active-B12 / methylmalonic acid assessment. [1]
Some evidenceStrongAdults using spirulina as an antioxidant or anti-inflammatory supplement
No UK-authorised antioxidant or anti-inflammatory claim for spirulina. The cell-biology phycocyanin antioxidant data is real; clinical translation at oral food-supplement doses is modest. Evidence for clinical anti-inflammatory benefit (rheumatoid arthritis, allergic rhinitis, NAFLD) is small and inconsistent.
Some evidenceLimitedAdults with phenylketonuria (PKU)
CONTRAINDICATED. Spirulina is high in phenylalanine (~3-5% dry weight). People with PKU cannot metabolise dietary phenylalanine and develop neurotoxicity from high intake. [3]
Some evidenceStrongAdults with autoimmune disease or on immunosuppressant medication
Disclose any spirulina use to the team managing the autoimmune condition or immunosuppression. Theoretical immunomodulation (the phycocyanin / polysaccharide effect on cytokine release) warrants disclosure even though direct contraindication evidence is limited.
Some evidenceLimitedPregnant or breastfeeding women, or women trying to conceive
Avoid concentrated supplement extracts. Food-tier culinary additions (small amounts in smoothies, salads) have historical use without obvious harm signals at population level. Concentrated supplement-tier safety in pregnancy is not formally established. Microcystin-contamination concern is amplified in pregnancy because of foetal hepatotoxin sensitivity. Talk to your midwife if uncertain. [9]
Some evidenceLimited
How it works
Spirulina's biological activity in human consumption is best understood as a dense protein and pigment source rather than a single-mechanism therapeutic intervention. The relevant mechanism axes:
Phycocyanin antioxidant activity. Phycocyanin is a brilliant-blue chromophore-protein complex that gives spirulina its characteristic colour. In cell-biology assays it has substantial antioxidant capacity — scavenging peroxyl and hydroxyl radicals, and modulating Nrf2-dependent antioxidant gene expression. It also has documented anti-inflammatory activity in animal-model preparations via NF-κB modulation. Phycocyanin is the single most-marketed bioactive in spirulina supplementation, but oral bioavailability of intact phycocyanin is low (the pigment-protein complex is digested in the stomach and small intestine, releasing phycocyanobilin and constituent amino acids). Whether the in-vitro antioxidant effect translates to clinical antioxidant outcomes at oral food-supplement doses is the standard polyphenol question — modest at best.
Protein and amino-acid contribution. Spirulina is roughly 60-70% protein by dry weight — among the highest plant-source protein densities. The amino-acid profile is complete (all essential amino acids present), though methionine and lysine concentrations are below soy and dairy reference levels. As a protein source, spirulina contributes nutritional protein in the same way other plant-protein supplements do.
Gamma-linolenic acid (GLA). Spirulina contains GLA at roughly 1% of dry weight (similar order to evening primrose oil but lower than borage seed oil). GLA is an n-6 long-chain polyunsaturated fatty acid that is metabolised to dihomo-γ-linolenic acid (DGLA) and ultimately to anti-inflammatory series-1 prostaglandins. The GLA contribution from a typical spirulina supplement (3 g/day delivers ~30 mg GLA) is small relative to evening primrose oil (typically 240-480 mg GLA / day in trial protocols) — spirulina is not a primary GLA delivery route.
Corrinoid B12-analogues — pseudo-vitamin-B12. Spirulina contains roughly 100-300 µg/100 g of corrinoid molecules that bind to B12 microbiological assay antibodies and are listed as "vitamin B12" on some labels. These corrinoids are NOT human-bioavailable as vitamin B12 — the principal corrinoid is pseudovitamin B12 (with adenine in place of 5,6-dimethylbenzimidazole as the lower nucleotide ligand), which is not absorbed via the human intrinsic-factor pathway. There is published concern that pseudo-B12 may compete with active B12 at the cubam receptor and cause functional B12 deficiency in heavy users (Watanabe 2002, Watanabe 2014). Vegans relying on spirulina for B12 are at meaningful risk of B12 deficiency despite "B12 detected" on the label. The UK BDA and Vegan Society both flag spirulina as NOT a reliable B12 source.
Iron. Spirulina iron content is high but bioavailability is modest (heme iron is absent — the iron is in non-heme forms). Spirulina is a contributor to iron intake for plant-based eaters but is not a primary iron-deficiency intervention.
Microcystin contamination — the safety axis. Spirulina cultivation is open-pond and is vulnerable to contamination by toxin-producing Microcystis cyanobacteria. Microcystins are hepatotoxic peptide toxins (microcystin-LR is the most-studied). Documented clinical episodes have occurred from contaminated commercial spirulina. Reputable suppliers screen each production batch using LC-MS or ELISA assays and disclose the result. Reputable suppliers also screen for BMAA (β-methylamino-L-alanine), a non-protein amino acid produced by some cyanobacteria that has been associated with neurodegenerative-disease epidemiological signals (the Cox / Banack 2005-onward hypothesis). The clinical significance of low-level BMAA exposure from spirulina is debated; the safety-conscious response is to choose product with the screening disclosure visible.
Common myths
Myth""Spirulina is a complete plant-based source of vitamin B12 for vegans.""
RealityFALSE — and clinically dangerous. The B12 detected on spirulina labels is principally pseudovitamin B12, a corrinoid analogue that is NOT human-bioavailable and may interfere with active- B12 utilisation. The UK BDA, Vegan Society, NHS, and BMJ Best Practice all flag spirulina as NOT a reliable B12 source. Vegans need methylcobalamin or cyanocobalamin supplements or B12-fortified foods. This is the single most important consumer-education point for spirulina. [1]
Myth""Spirulina contains 92 of 102 minerals" / "covers your whole multivitamin needs.""
RealityMarketing claim with no factual basis. Spirulina contains a normal range of minerals at modest concentrations — it is not a substitute for a multivitamin and does not contain "92 of 102 minerals" (a marketing trope without a primary source). Critical nutrients NOT delivered in meaningful amounts include active vitamin B12, vitamin D, vitamin K2, calcium (modest only), iodine, and selenium.
Myth""Spirulina detoxes / cleanses heavy metals.""
RealityNon-regulated marketing language. Some cell-biology and animal-model studies have reported chelation-like behaviour of spirulina constituents toward heavy metals; the clinical relevance at oral food-supplement doses is not established. UK NICE pathways for diagnosed heavy-metal toxicity (lead poisoning, mercury toxicity) are clinical and use specific chelators (DMSA, succimer) under hospital supervision — spirulina is not in the pathway.
Myth""Spirulina is contamination-free because it's natural.""
RealityOpen-pond cultivation is vulnerable to contamination by toxin-producing Microcystis cyanobacteria (microcystin) and BMAA-producing cyanobacteria. Reputable suppliers screen each batch and disclose. Generic / unbranded spirulina without screening disclosure is a meaningful safety question.
Myth""Spirulina boosts immunity / fights cancer.""
RealityNo UK-authorised immunity or cancer claim. The phycocyanin cell-biology immunomodulation literature does not translate to clinical-endpoint trial evidence. UK NICE pathways for cancer treatment are condition-specific; spirulina is not in any of them.
What people say online
Spirulina discourse on TikTok and Reddit clusters around four narratives: "vegan complete protein + B12 source" (the B12 portion is the load-bearing safety concern); "natural energy and detox" (mostly inaccurate framings); blood-pressure / cardiovascular benefit (real but modest signal); and microcystin / BMAA safety questions (the sophisticated-consumer cluster, mostly accurate). This section surfaces the discourse without naming individuals.
Trending claims
- TikTok #veganism + r/vegan + r/Plant-basedhigh visibility
Claim: Spirulina is the complete vegan superfood with B12 and protein
Reality check: Protein portion: true (~60-70% by dry weight). B12 portion: false. Spirulina corrinoids are pseudo-B12 (non-bioavailable; Watanabe 2002, 2014) and may interfere with active B12 absorption. UK BDA, Vegan Society, and NHS guidance unambiguous: vegans need methylcobalamin or cyanocobalamin supplements (or B12-fortified foods). Spirulina is fine as a plant- protein adjunct; it is NOT a B12 source.
- TikTok #detox + alternative-medicine Redditmedium visibility
Claim: Spirulina detoxes radiation / heavy metals / toxins
Reality check: The "Chernobyl spirulina protocol" narrative refers to limited reports of spirulina use post-Chernobyl in children with documented internal radiation exposure — not a UK NHS pathway, and not generalisable to undefined "toxin burden". For diagnosed heavy-metal toxicity UK NICE pathway is specific clinical chelators (DMSA, succimer) under hospital supervision. Self- supplementing spirulina for undefined "detox" is not a recognised pathway.
- TikTok #naturalremedies + r/Hypertensionmedium visibility
Claim: Spirulina lowers blood pressure naturally — replace your BP meds
Reality check: The BP signal is real — Machowiec 2021 (PMID 34578932) meta-analysis reported SBP -4.6 mmHg + DBP -7.0 mmHg. But "replace your meds" is the wrong action — UK NICE NG136 (Hypertension) pathway uses thiazide / ACEi / ARB / CCB based on age + ethnicity + comorbidity; stopping prescribed antihypertensive medication on the strength of a modest food-supplement BP signal is unsafe. Spirulina can be an adjunct conversation with your GP, not a replacement. [7]
- TikTok + supplement-industry Redditlow visibility
Claim: Open-pond spirulina is safe — microcystin only happens in lakes
Reality check: Inaccurate. Open-pond cultivation is genuinely vulnerable to Microcystis contamination — documented clinical episodes have occurred from contaminated commercial spirulina. Reputable suppliers screen each batch by LC-MS or ELISA and disclose. Generic / unbranded spirulina without screening disclosure is a meaningful safety question; the contamination risk is real, not theoretical.
Where the conversation lives
- TikTok hashtags: #spirulina, #vegansupplements, #greensuperfood, #detox, #naturalbp
- Reddit subs: r/Supplements, r/vegan, r/Plant-based, r/Hypertension, r/Nutrition
- Forums: Examine.com (paid evidence comparator), Vegan Society UK
Questions people are searching
- Is spirulina really a vegan B12 source?
- Spirulina or chlorella — which?
- Can I eat spirulina if I have hyperthyroidism?
- My spirulina tastes / smells weird — is it off?
- Will spirulina lower my blood pressure?
- Is spirulina safe for pregnancy?
Who drives the discourse: The discourse is driven by four creator classes: vegan- nutrition creators (the B12-source question — increasingly accurate as the pseudo-B12 message spreads, sometimes still overstated); detox / wellness creators (the Chernobyl / radiation / heavy-metal framings — mostly inaccurate); blood-pressure / cardiovascular creators (the BP signal — real but sometimes overstated as a medication replacement); and quality-conscious supplement creators (the microcystin / BMAA screening question — accurate). Verifera editorial does not name individuals.
Social-media trends change quickly. This section is editorial commentary on what people are searching for — not a recommendation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Spirulina (Arthrospira platensis, Arthrospira maxima). Each answer is editorial and links to its evidence in the Sources list below.
I'm vegan — can I get my B12 from spirulina?
No. The B12 detected on spirulina labels is principally pseudovitamin B12, a corrinoid analogue that is NOT human-bioavailable as active vitamin B12. UK BDA, Vegan Society, and NHS all flag spirulina as NOT a reliable B12 source. Vegans need methylcobalamin or cyanocobalamin supplements (typically 25-1000 µg/day depending on regimen) or B12-fortified foods (UK plant drinks, nutritional yeast, fortified breakfast cereals). [1]
How do I know if my spirulina is contamination-free?
Look for the supplier's batch-screening disclosure for microcystin and (ideally) BMAA. Reputable suppliers test every batch using LC-MS or ELISA and provide the certificate of analysis on request. Cyanotech Spirulina Pacifica (Hawaii) and a small number of European producers have made the screening certification a routine commercial commitment. Generic / unbranded spirulina without screening disclosure is a meaningful safety question.
Spirulina or chlorella — which?
Different organisms with different profiles. Chlorella is a true single-celled green alga (eukaryote) with a tougher cell wall (cell-wall-cracked / sonicated processing required for bioavailability). Spirulina is a cyanobacterium (prokaryote) without the cell-wall-bioavailability issue but with the microcystin-contamination concern that is specific to cyanobacteria. Chlorella has slightly higher protein density and chlorophyll content; spirulina has phycocyanin and the documented marketing tradition. Neither has UK-authorised health claims.
Can I eat spirulina if I have hyperthyroidism?
Modest cautions. Spirulina iodine content is variable but usually modest. Cyanobacteria can also contain other iodine species. The conservative position in autoimmune thyroid disease (Hashimoto, Graves) is disclosure to the endocrinology team and avoidance of products without batch testing for iodine content. [10]
My spirulina tastes / smells weird — is it off?
Spirulina has a characteristic strong, savoury, slightly fishy odour — that is normal. A sour, mouldy, or putrid odour is a quality concern; discard and source from a different supplier. Storage in a cool, dry, dark place extends shelf life.
UK regulatory landscape
UK regulatory tier: Food supplement
Spirulina sits under the UK Food Supplements (England) Regulations 2003 (and devolved equivalents). There is NO UK-authorised Article 13.1 health claim for spirulina; EFSA's evaluation of spirulina-related claims is on hold. Arthrospira platensis and A. maxima have long history of EU and West-African / Mexican food / supplement use predating 15 May 1997 and are NOT novel foods in whole-biomass form. Concentrated phycocyanin extracts may require case-by-case Novel Foods assessment.
What crosses the tier
| Condition | Crosses to |
|---|---|
| Marketing as a vitamin B12 source for vegans | |
| Marketing for diagnosed hypertension as a treatment / medication replacement | |
| Marketing for radiation / heavy-metal "detox" | |
| Marketing without microcystin / BMAA batch-testing disclosure | |
| Marketing for phenylketonuria (PKU) patients |
Permitted claims
NO UK Article 13.1 authorised health claim exists for spirulina. The supplement may be sold under food-supplement tier as long as no specific function or disease-risk- reduction claim is made. Generic factual description (e.g., "spirulina is a cyanobacterium consumed as a plant-protein adjunct") is permitted.
Cross-jurisdiction note
Spirulina is widely consumed in the EU, US, and across Asia. Hawaii (US), Spain (EU), India, China, and Israel are the major commercial producers; Hawaii product typically carries the stricter microcystin / BMAA testing disclosure. No major jurisdiction has authorised disease- treatment claims for spirulina; its food-supplement status is consistent globally.
UK regulatory rules evolve. This summary is editorial — businesses should consult regulatory counsel; consumers should consult their pharmacist or GP.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Lipid profile / cardiovascular markers
LimitedEvidencelimitedSeveral small RCTs have reported modest reductions in total cholesterol and LDL with spirulina supplementation at 1-8 g/day for 8-12 weeks. Trial sizes small, effect sizes modest. UK NICE NG238 cardiovascular pathway does not include spirulina. [11]
Allergic rhinitis
LimitedEvidencelimitedSome small RCTs (Cingi 2008, others) have reported reduced allergic-rhinitis symptom scores with spirulina supplementation. Effect sizes modest; trial heterogeneity substantial. UK NICE rhinitis pathway is intranasal corticosteroid + antihistamines first. [12]
Vitamin B12 deficiency in vegans
InsufficientEvidenceinsufficientTrial evidence specifically shows that spirulina does NOT correct B12 deficiency. The corrinoid B12-analogue is not human-bioavailable. UK BDA, Vegan Society, NHS, and BMJ Best Practice all flag spirulina as NOT a reliable B12 source. [1]
Type 2 diabetes — adjunctive use
LimitedEvidencelimitedSmall RCTs in type 2 diabetes have reported modest reductions in fasting glucose and HbA1c with spirulina at 1-8 g/day for 8-12 weeks. UK NICE NG28 (type 2 diabetes management) does not include spirulina. [13]
Iron-deficiency anaemia
InsufficientEvidenceinsufficientSpirulina is not the appropriate intervention for diagnosed iron-deficiency anaemia. UK NHS pathway is ferrous sulphate / ferrous fumarate / ferrous bisglycinate at clinical-tier doses. Spirulina iron is modestly bioavailable but the supplement-tier iron content does not match therapeutic-iron supplementation. [14]
Cancer adjunct
InsufficientEvidenceinsufficientNo supportive trial evidence for spirulina as a cancer prevention or treatment adjunct in UK clinical pathways. Talk to the oncology team before adding any supplement during cancer treatment. [15]
Effect matrix — per-condition evidence
Per-outcome summary of the published trial corpus: dose ranges studied, duration, evidence grade, and direction of effect. Each row is a citable claim.
| Outcome | Population | Dose | Duration | Evidence | Direction | Sources |
|---|---|---|---|---|---|---|
| Blood pressure reduction (hypertensive adults) | adults | 1000–8000 mg | 4–12 wk | LimitedEvidencelimited | improvement | PMID 34578932 |
| Machowiec 2021 meta-analysis 5 RCTs n=230. Systolic BP MD -4.59 mmHg (95% CI -8.20 to -0.99, I²=65%); diastolic BP MD -7.02 mmHg (95% CI -8.86 to -5.18, I²=11%). Effects particularly pronounced in hypertensive participants. UK NICE NG136 hypertension pathway: lifestyle then ACE-I/ARB/ CCB/thiazide; spirulina not in pathway. Small total n + trial-quality concerns cap grade at LIMITED. | ||||||
| Lipid profile (total cholesterol + triglycerides) | adults | 1000–8000 mg | 4–12 wk | LimitedEvidencelimited | improvement | PMID 33724587 |
| Hoang 2021 umbrella review of 50 meta-analyses — spirulina among phytonutrients with beneficial lipid + glycemic effects. Inter-trial heterogeneity substantial; individual effect sizes modest. UK NICE NG238 lipid pathway: statins where indicated; spirulina not in pathway. | ||||||
| Glycaemic control (fasting glucose / HbA1c) | adults | 1000–8000 mg | 4–12 wk | LimitedEvidencelimited | improvement | PMID 33724587 |
| Hoang 2021 umbrella review — spirulina among phytonutrients with beneficial glycemic-control effects (14 glycemic-control analyses across 50 studies). Inter-trial heterogeneity; effect sizes modest. UK NICE NG28 type-2 diabetes pathway: metformin and structured diet; spirulina not in pathway. Not a substitute for medical management of diabetes. | ||||||
| Vitamin B12 deficiency (pseudo-B12 reliability) | general | — | — | InsufficientEvidenceinsufficient | no change | — |
| Body-text flags Watanabe 2002 / 2014 work showing spirulina pseudo-B12 is NOT bioavailable to humans — important consumer-warning row because spirulina is marketed to vegans as a B12 source. magnitude=no_change for the actual B12-deficiency outcome (despite appearing on supplement labels as a B12 source). Citations empty pending Watanabe PMID grounding in body-text. | ||||||
Evidence grades follow the editorial convention: strong > moderate > limited > very_limited > insufficient. Direction reports the trial corpus consensus (improvement / no_change / mixed / decrement). Schema cross-emitted at MedicalSubstance.relevantClinicalCondition[].
Clinical literature review
The spirulina literature splits into four threads: blood pressure and hypertension (Machowiec 2021 PMID 34578932 Nutrients meta-analysis 5 RCTs n=230); cardiovascular risk umbrella (Hoang 2021 PMID 33724587 Phytotherapy Research — spirulina among phytonutrients with beneficial lipid + glycemic effects); pseudo-B12 / vegan B12 reliability (Watanabe 2002, 2014 work — pseudo-B12 not bioavailable); and microcystin / BMAA contamination safety (case-report and surveillance literature). UK NICE NG238 (Cardiovascular) and NG136 (Hypertension) do NOT include spirulina in any pathway; UK BDA + Vegan Society B12 guidance is unambiguous that spirulina is NOT a reliable B12 source.
Key trials
Machowiec P, Ręka G, Maksymowicz M, Piecewicz-Szczęsna H, Smoleń A · 2021 · Nutrients · PMID 34578932
Finding: 5 RCTs of spirulina supplementation (1-8 g/day) on blood pressure. Significant reductions vs control: systolic BP (MD -4.59 mmHg, 95% CI -8.20 to -0.99, I²=65%); diastolic BP (MD -7.02 mmHg, 95% CI -8.86 to -5.18, I²=11%). Effects particularly pronounced in hypertensive participants.
Relevance: The most-recent meta-analytic blood-pressure signal for spirulina. Modest but statistically significant reduction. Trial-quality concerns (small total n, short durations, single-centre studies dominate); UK NICE NG136 (Hypertension) does NOT include spirulina in pathways.
Hoang T, Kim J · 2021 · Phytother Res · PMID 33724587
Finding: Umbrella review of phytonutrient supplements and cardiovascular biomarkers. 50 studies included covering 16 BP analyses, 25 lipid analyses, 14 glycemic-control analyses. Aloe vera, Nigella sativa, and spirulina were each associated with beneficial effects on BOTH lipid profiles AND glycemic control. Ginger and Hibiscus sabdariffa lowered systolic BP. Inter-trial heterogeneity was substantial; results "must be interpreted with caution".
Relevance: The broadest contemporary review situating spirulina alongside other phytonutrients. Confirms a real metabolic-marker signal but flags inter-trial heterogeneity. UK NICE pathways remain spirulina-free.
Systematic reviews
- pmid:34578932
Machowiec 2021 Nutrients — 5 RCTs n=230, spirulina 1-8 g/day for 2-12 weeks. SBP -4.59 mmHg + DBP -7.02 mmHg vs control, effects strongest in hypertensive subgroup.
- pmid:33724587
Hoang 2021 Phytother Res — umbrella review including spirulina alongside Aloe vera + Nigella sativa as phytonutrients with beneficial lipid + glycemic effects. Inter-trial heterogeneity flagged.
Evidence quality summary
Blood pressure reduction in hypertensive patients — LIMITED- to-MODERATE certainty (Machowiec 2021 PMID 34578932; small total n, BP reductions clinically meaningful but UK NICE NG136 does not include). Cardiovascular risk markers umbrella — LIMITED certainty (Hoang 2021 PMID 33724587; heterogeneity flagged). Vegan B12 reliability — INSUFFICIENT / UNSAFE (pseudo-B12 mechanism, Watanabe series). Microcystin contamination safety — HIGH certainty for the risk; reputable batch-testing eliminates the practical concern. Immune function biomarker signals — LIMITED certainty.
Known gaps
- Larger UK-context RCT of batch-tested spirulina supplementation on BP and cardiovascular outcomes (existing meta-analyses are dominated by smaller international trials).
- Standardised UK pregnancy + breastfeeding safety data (limited and indirect).
- Direct head-to-head trial of spirulina vs other plant-protein supplements at matched protein dose.
- UK surveillance data on microcystin contamination prevalence in commercially-sold spirulina (rare incidents documented, no UK registry).
This summarises the published evidence as of the last review date — it is not advice for your specific situation. Talk to your pharmacist or GP.
Safety
Properly sourced spirulina from a reputable supplier with batch-screening for microcystin and BMAA is well-tolerated for most adults. The critical considerations are (1) DO NOT use spirulina as a vitamin B12 source — the B12 in spirulina is not human-bioavailable; (2) PKU is a hard contraindication because of phenylalanine content; and (3) microcystin contamination is a real risk in non-spec product.
Talk to your pharmacist or GP first if you:
- You have phenylketonuria (PKU) — CONTRAINDICATED.
- You are vegan and currently rely on spirulina for B12 — switch to active vitamin B12 (methylcobalamin / cyanocobalamin) immediately.
- You have diagnosed autoimmune disease or take immunosuppressant medication — disclose use; theoretical immunomodulation.
- You have a known cyanobacterium / algae allergy — avoid.
- You are pregnant or breastfeeding — avoid concentrated supplements; tea-tier culinary use historical.
- You take warfarin — modest theoretical signal; disclose to anticoagulation clinic.
- You have hyperthyroidism / Hashimoto / Graves — disclose; iodine content variable.
Common side effects: Generally well-tolerated. Mild GI upset (nausea, bloating). Spirulina has a distinctive savoury / fishy taste many users find off-putting initially.
Pregnancy and breastfeeding
Avoid concentrated spirulina supplement extracts in pregnancy. The microcystin-contamination concern is amplified in pregnancy because of foetal hepatotoxin sensitivity. Food-tier consumption (small culinary additions) has historical use without obvious harm signals at population level. Talk to your midwife or GP if you are uncertain.
Avoid concentrated spirulina supplements during exclusive breastfeeding. The microcystin-toxin transfer-into-breast- milk question is unsettled; prefer to avoid for breastfeeding mothers. Talk to your midwife or health visitor before adding.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Phenylketonuria (PKU) — high phenylalanine content; CONTRAINDICATED.
- Documented cyanobacterium / algae allergy.
- Heavy use as a B12 substitute in vegans (the pseudo-B12 issue).
- Hypersensitivity to spirulina or supplement constituents.
Drug interactions
Immunosuppressants (ciclosporin, tacrolimus, biologic DMARDs, methotrexate) · medium
Effect: Phycocyanin and other spirulina polysaccharides have documented immunomodulatory activity in cell-biology and animal-model studies (NK-cell activation, cytokine modulation). Theoretical pharmacodynamic opposition to immunosuppression — most clinically relevant in solid- organ-transplant maintenance and in autoimmune-disease biologic therapy.
Mechanism: Phycocyanin modulates NF-κB signalling; the immunomodulation is plausible at cell-biology level. Translation to clinically-meaningful interference with prescribed immunosuppression at oral food-supplement doses is modest but worth disclosure.
Action: Tell the team managing your transplant, rheumatology / dermatology biologic therapy, or other prescribed immunosuppression about any spirulina supplement (including in green-superfood blends).
Source: BNF immunosuppressants + UK NICE pathway-specific guidance
Vitamin B12 supplements — pseudo-B12 in spirulina may compete with active B12 at cubam receptor; functional implication for heavy users (Watanabe 2002, 2014).
Warfarin — modest theoretical signal (variable vitamin K content); disclose to anticoagulation clinic. NB: chlorella has substantially higher vitamin K1 content than spirulina — risk is real for chlorella + warfarin (see chlorella entry), modest for pure spirulina.
Oral diabetes medicines — theoretical mild hypoglycaemic effect at high doses.
Anti-cancer agents — theoretical immunomodulation; disclose to oncology team per routine supplement-disclosure rule.
Tell your prescriber if you take any of these combinations. This is not personalised advice.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild GI upset (nausea, bloating, soft stools) particularly when starting at high doses.
- Strong distinctive taste — many users find spirulina aftertaste off-putting.
Rare side effects
- Allergic reactions — rare.
- Acute hepatotoxicity from microcystin-contaminated product (rare in commercial UK retail; risk is non-spec / unscreened product).
- Theoretical autoimmune-disease activity changes.
- Functional B12 deficiency in heavy users relying on spirulina for B12 (the pseudo-B12 mechanism — substantiated risk).
How to take it
- Typical supplemental range
- Trial-evidenced doses span 1-8 g/day of dried biomass (commonly delivered as 6-12 tablets/day). UK supplement labels typically recommend 3-6 g/day. Higher doses are not proportionally better-evidenced.
- Timing
- Daily — any time of day. Some users prefer with meals to mitigate the strong taste.
How to spot quality
Look for
- Species declared (Arthrospira platensis or Arthrospira maxima).
- Phycocyanin content stated (the standardisation marker; typical 6-20% by dry weight in good product).
- BATCH-TESTING for microcystin AND BMAA, with the disclosure on the spec sheet or product page. This is the single most important quality marker for spirulina.
- Heavy-metal screen (lead, arsenic, mercury, cadmium) with limits below food-grade thresholds.
- Country of cultivation declared. Hawaiian and European cultivation generally has tighter regulatory oversight than some other global sources.
- GMP-certified manufacture.
Red flags
- No microcystin / BMAA screening disclosure.
- Marketing as a vitamin B12 source for vegans — DANGEROUS, see myth-correction above.
- Marketing as "92 of 102 minerals" or as a multivitamin substitute.
- Marketing as "heavy-metal cleansing" / cleansing-marketing — non-regulated language.
- Marketing for cancer remedies, immune-boosting, or autoimmune-disease "support".
- No species declaration.
- No phycocyanin content stated.
- Combination products with chlorella or sea-moss without combined-dose declaration.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Chlorella (Chlorella vulgaris, Chlorella pyrenoidosa)
Limited evidenceThe classic green-superfood pairing — combined commonly in plant-based daily-greens products. Mechanism-additive on the protein / chlorophyll / general-nutrition axis.
Spirulina (cyanobacterium, prokaryote) and chlorella (true green alga, eukaryote) share a protein-dense, chlorophyll-rich, plant-based nutrition profile. Combined "green-superfood" products typically deliver 1-3 g of each, plus often wheatgrass, barley grass, or other plant-source greens.
The combination has no specific synergy mechanism — both contribute protein, chlorophyll, modest mineral content, and broad polyphenol / pigment antioxidant capacity. UK marketing must respect the EFSA Article 13 hold for both — neither can carry a UK-authorised health claim.
The pairing is also product-marketing-driven: combining the two gives a product with complementary marketing narratives (spirulina = phycocyanin + B-vitamin-like; chlorella = chlorophyll + cell-wall-cracked + heavy-metal-binding myth). Camden's editorial position is that both should be sourced from suppliers with the relevant batch-testing disclosure (microcystin / BMAA for spirulina; cell-wall-cracked processing and heavy-metal screen for chlorella).
Evidence: Mechanism-additive on protein / chlorophyll axis. No specific combination trial evidence for clinical endpoints.
Doses studied: 1-3 g/day spirulina + 1-3 g/day chlorella (cell-wall-cracked) in a green-superfood blend. Often with additional plant-source greens.
Vitamin B12
Strong evidenceCritical disclosure pairing — spirulina supplementation should be combined with active vitamin B12 (methylcobalamin or cyanocobalamin) in any vegan / plant-based regimen. The combination corrects the pseudo-B12 misperception.
Spirulina contains pseudo-B12 corrinoid analogues that are NOT human-bioavailable as active vitamin B12. Active vitamin B12 (methylcobalamin or cyanocobalamin) is required for normal methionine synthase and methylmalonyl-CoA mutase function — the substrates of the B12-deficiency clinical syndrome (megaloblastic anaemia, peripheral neuropathy, subacute combined degeneration of the cord, depressive symptoms).
A vegan or plant-based regimen including spirulina must include a separate active B12 source — methylcobalamin or cyanocobalamin supplements (typically 25 µg/day daily, or 1000 µg/week intermittent), or B12-fortified foods. UK BDA and Vegan Society guidance is unambiguous on this point.
The combination is therefore not synergistic — it is defensive. Camden surfaces this combination here so that a consumer reading the spirulina entry has the canonical pairing available immediately.
Evidence: UK BDA, Vegan Society, NHS guidance all support the position that spirulina is NOT a B12 source and active B12 supplementation is required in vegan / plant-based regimens. [1]
Doses studied: Spirulina at user-chosen dose (1-6 g/day) PLUS active vitamin B12 (methylcobalamin or cyanocobalamin) 25 µg/day, or 1000 µg twice weekly, or 2000 µg weekly. Camden's vitamin-b12 entry covers the dosing rationale.
Iron
Limited evidencePlant-based iron-and-protein cluster — spirulina contributes both protein and modest iron; vitamin C combined with iron-containing meals supports absorption.
Spirulina is approximately 60-70% protein by dry weight and contains roughly 28-40 mg iron / 100 g dry weight (in non-heme form, with moderate bioavailability). The protein-iron contribution to a plant-based diet is real but modest at typical 3-6 g/day spirulina dosing — about 1-3 mg iron per serving.
Vitamin C combined with iron-containing meals enhances non-heme iron absorption (by reducing ferric to ferrous form and counteracting phytate / polyphenol absorption inhibition). The pairing is dietary rather than supplement-tier.
The combination is mechanism-supportive — spirulina contributes plant-protein and modest iron; a properly composed plant-based diet plus iron-rich foods at NHS Eatwell-Guide intake levels meets requirements without therapeutic-iron-level supplementation. Diagnosed iron-deficiency anaemia requires therapeutic iron via the GP, not spirulina.
Evidence: Mechanism well-established. No specific combination trial evidence on clinical endpoints. [6]
Doses studied: 3-6 g/day spirulina alongside vitamin-C-containing foods (citrus, peppers, broccoli, kiwi). Therapeutic iron supplementation for diagnosed deficiency is a separate clinical context.
Verifera™ editorial perspective
Why it matters. Spirulina sits on UK retail shelves with persistent "vegan B12 source" marketing that is genuinely unsafe for vegans relying on it. The pseudo-B12 unreliability (Watanabe 2002, 2014) is the load-bearing message, alongside the microcystin contamination concern in unscreened product. The cardiovascular and blood-pressure signal (Machowiec 2021 PMID 34578932 + Hoang 2021 PMID 33724587 umbrella) is modest but real. The Verifera editorial position is that this entry has to keep "spirulina is NOT a vegan B12 source" prominent at the top and surface the batch-testing requirement honestly.
Where Camden lands. Camden Medicals does NOT currently retail a single-active spirulina SKU. The entry serves as the canonical UK reference for the algae cluster alongside Camden's chlorella and sea-moss entries. For UK consumers researching this space: batch-tested spirulina (microcystin + BMAA screening disclosed) is the minimum quality standard; vegans should use methylcobalamin / cyanocobalamin for B12 rather than spirulina; PKU is an absolute contraindication.
If you want to explore further. For plant-based protein supplementation: UK NHS Eatwell Guide first (legumes, tofu, nuts, seeds, whole grains as primary plant-protein sources). Spirulina is an adjunct and cost-per-gram-protein is high relative to other plant sources. If you do add spirulina: batch-tested microcystin + BMAA disclosure is the minimum quality bar; reputable Hawaii / Taiwan / Spain / India suppliers generally disclose. If you have PKU: spirulina is contraindicated. If you are vegan needing B12: use methylcobalamin or cyanocobalamin (not spirulina).
How this entry was researched
Authoritative sources consulted:
- NHS Vitamin B12 or folate deficiency anaemia + Eatwell Guide pages
- NICE NG238 (Cardiovascular) + NG136 (Hypertension)
- UK BDA + Vegan Society B12 position statements
- GB Nutrition and Health Claims (NHC) Register (no authorised spirulina claim; EFSA Article 13 evaluations on hold)
- Verifera chlorella + sea-moss + vitamin-b12 entries (cross-cluster references)
- Cox/Banack BMAA literature for the neurodegenerative-disease epidemiological signal
- PubMed (via E-utilities MCP, 2026-05-12)
PubMed search terms:
spirulina blood pressure hypertension meta-analysis randomized
Literature search date: 2026-05-12
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.